smoking cessation

Reaching smoke-free: how can we improve smoking cessation treatment?

Created by
NDARC

This webinar explored the provision of smoking cessation treatments, including e-cigarettes, in the context of primary care.

It provided an overview of investigations into how smoking cessation treatment provision in the UK could be improved – and the roles prescription e-cigarettes may play – to further reduce the prevalence of smoking and meet England’s smoke-free 2030 target (≤ 5% smoking prevalence).

General Principles of Contingency Management for Smoking Cessation

Citation
Aonso Diego, G., & Kulhánek, A. (2022). General principles of contingency management for smoking cessation. Adiktologie, 22(2), 126–131. https://doi.org/10.35198/01-2022-002-0006
Publication Date

Contingency management (CM) is a psychological treatment based on operant conditioning. It consists of providing incentives in exchange for achieving a target behaviour such as abstinence or other treatmentrelated variables (e.g. session attendance, adherence to medication). The objective of this article was to introduce the rationale of CM for substance use and, more specifically, for smoking cessation.

Changes in Smoking Cessation–Related Behaviors Among US Adults During the COVID-19 Pandemic

Citation
Bandi P, Asare S, Majmundar A, et al. Changes in Smoking Cessation–Related Behaviors Among US Adults During the COVID-19 Pandemic. JAMA Netw Open. 2022;5(8):e2225149. doi:10.1001/jamanetworkopen.2022.25149

Key Points

Question  Did smoking cessation–related behaviours change during the COVID-19 pandemic in the US?

Findings  This cross-sectional study among 788 008 US adult smokers found that the annual prevalence of past-year quit attempts decreased for the first time since 2011, from 65.2% in 2019 to 63.2% in 2020.

Kenya to include smoking cessation drugs as essential medicines

The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction. The World Health Organization said the two drugs bring “a powerful shift in the fight against the tobacco epidemic.” The two are bupropion and varenicline, which are more effective than the current cessation drugs, which contain nicotine.

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes A Randomized Clinical Trial

Citation
Russo C, Walicka M, Caponnetto P, et al. Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(6):e2217709. doi:10.1001/jamanetworkopen.2022.17709
Publication Date
Abstract

Importance  Evidence of effective smoking cessation interventions in patients with diabetes is limited. The unique behavioral and metabolic characteristics of smokers with type 2 diabetes warrants a randomized clinical trial of the smoking cessation drug varenicline.

Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily A Randomized Clinical Trial

Citation
King A, Vena A, de Wit H, Grant JE, Cao D. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e220951. doi:10.1001/jamanetworkopen.2022.0951
Publication Date

Abstract

Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019

Citation
Chen R, Pierce JP, Leas EC, et alEffectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019Tobacco Control Published Online First: 07 February 2022. doi: 10.1136/tobaccocontrol-2021-056901
Publication Date
Abstract

Objective To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.

Identifying content-based engagement patterns in a smoking cessation website and associations with user characteristics and cessation outcomes: a sequence and cluster analysis

Citation
Olga Perski, PhD, Noreen L Watson, PhD, Kristin E Mull, MS, Jonathan B Bricker, PhD, Identifying Content-Based Engagement Patterns in a Smoking Cessation Website and Associations With User Characteristics and Cessation Outcomes: A Sequence and Cluster Analysis, Nicotine & Tobacco Research, Volume 23, Issue 7, July 2021, Pages 1103–1112, https://doi.org/10.1093/ntr/ntab008
Publication Date

Tobacco smoking is the greatest cause of sickness and early death worldwide, with 8 million people dying each year from a smoking-related condition. The use of pharmaceutical or behavioural assistance improves smokers' chances of quitting; nonetheless, the majority of smoking cessation efforts are unassisted.

Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial

Citation
Busch, A.M., Nederhoff, D.M., Dunsiger, S.I. et al. Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial. BMC Psychiatry 21, 104 (2021). https://doi.org/10.1186/s12888-021-03113-5
Publication Date

Background:

Rates of smoking among those with serious mental illness (SMI) are two to three times higher than for the general population. Smoking is rarely addressed in mental health settings. Innovative outreach and treatment strategies are needed to address these disparities.